Skip to main content

Find Clinical Trials

Home
Conditions
Liver Neoplasms

Clinical trial condition

Liver Neoplasms

Explore clinical trials studying Liver Neoplasms. Study availability and eligibility vary by location and protocol.

1,743 public trials 464 recruiting studies

Refine in advanced search Browse all conditions

Liver Neoplasms trial results

Enrolling by Invitation

Application of Integrated Proteomic and Serum Metabolomic Analysis in Assessing the Efficacy and Prognosis of TACE Combined With Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma

NCT06540508

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

A Post Approval Study to Evaluate Safety and Effectiveness of Multicompartmental Dosimetry Planning.

NCT07669727

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.

NCT06786429

Conditions: Adenocarcinoma, Anxiety Disorders, Behavior, +38 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Dapagliflozin Add-on in Unresectable HCC With Metabolic Syndrome

NCT07729592

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

The Efficacy and Safety of Donafenib Plus PD-1/L1 Monoclonal Antibodies Plus TACE or HAIC as First-line Treatment for Unresectable Hepatocellular Carcinoma A Multi-center, Retrospective Clinical Study

NCT07724951

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Sun Yat-sen Memorial Hospital Guangzhou, Guangdong, China

Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

Zhujiang Hospital of Southern Medical University Guangzhou, Guangdong, China

The First Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China

View Trial Details

Not Yet Recruiting

Inter-Individual Tumor Heterogeneity on 3D-MRE for Predicting Response to Conversion Therapy in Liver Cancer

NCT07716345

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Phase Ib/II Multicenter Randomized Control Study of Peri-operative Treatment With Combination of CTLA-4, PD-1 Antibodies and Bevacizumab in Resectable HCC (Prophet)

NCT07714317

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Safety and Feasibility of CIK Cell Therapy in HCC After Tumor Resection

NCT07709299

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Liver Transplant and Surgery Research Center, Imam Khomeini Hospital, Tehran University of Medical Sciences Tehran, Tehran Province, Iran

View Trial Details

Not Yet Recruiting

Application of Super-Resolution Ultrasound (SRUS) in Liver Tumor

NCT07707661

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Peritumoral MRE Stiffness for Predicting Resection Margin Status and Recurrence in Liver Cancer

NCT07704216

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations: Not specified

View Trial Details